Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease - PubMed (original) (raw)
Review
doi: 10.1038/sj.mp.4001854. Epub 2006 Jun 20.
Affiliations
- PMID: 16786033
- DOI: 10.1038/sj.mp.4001854
Review
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
I J Martins et al. Mol Psychiatry. 2006 Aug.
Abstract
High fat diets and sedentary lifestyles are becoming major concerns for Western countries. They have led to a growing incidence of obesity, dyslipidemia, high blood pressure, and a condition known as the insulin-resistance syndrome or metabolic syndrome. These health conditions are well known to develop along with, or be precursors to atherosclerosis, cardiovascular disease, and diabetes. Recent studies have found that most of these disorders can also be linked to an increased risk of Alzheimer's disease (AD). To complicate matters, possession of one or more apolipoprotein E epsilon4 (APOE epsilon4) alleles further increases the risk or severity of many of these conditions, including AD. ApoE has roles in cholesterol metabolism and Abeta clearance, both of which are thought to be significant in AD pathogenesis. The apparent inadequacies of ApoE epsilon4 in these roles may explain the increased risk of AD in subjects carrying one or more APOE epsilon4 alleles. This review describes some of the physiological and biochemical changes that the above conditions cause, and how they are related to the risk of AD. A diversity of topics is covered, including cholesterol metabolism, glucose regulation, diabetes, insulin, ApoE function, amyloid precursor protein metabolism, and in particular their relevance to AD. It can be seen that abnormal lipid, cholesterol and glucose metabolism are consistently indicated as central in the pathophysiology, and possibly the pathogenesis of AD. As diagnosis of mild cognitive impairment and early AD are becoming more reliable, and as evidence is accumulating that health conditions such as diabetes, obesity, and coronary artery disease are risk factors for AD, appropriate changes to diets and lifestyles will likely reduce AD risk, and also improve the prognosis for people already suffering from such conditions.
Similar articles
- Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM, Thorngate FE, Katoh-Fukui Y, Hamanaka H, Williams DL, Fujita S, Lamb BT. Mann KM, et al. Hum Mol Genet. 2004 Sep 1;13(17):1959-68. doi: 10.1093/hmg/ddh199. Epub 2004 Jun 30. Hum Mol Genet. 2004. PMID: 15229191 - APOE and cholesterol homeostasis in Alzheimer's disease.
Leduc V, Jasmin-Bélanger S, Poirier J. Leduc V, et al. Trends Mol Med. 2010 Oct;16(10):469-77. doi: 10.1016/j.molmed.2010.07.008. Trends Mol Med. 2010. PMID: 20817608 Review. - The involvement of lipids in Alzheimer's disease.
Lim WL, Martins IJ, Martins RN. Lim WL, et al. J Genet Genomics. 2014 May 20;41(5):261-74. doi: 10.1016/j.jgg.2014.04.003. Epub 2014 May 2. J Genet Genomics. 2014. PMID: 24894353 Review. - Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?
Michikawa M. Michikawa M. J Neurosci Res. 2003 Apr 15;72(2):141-6. doi: 10.1002/jnr.10585. J Neurosci Res. 2003. PMID: 12671988 Review. - Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J, Donkin J, Wellington C. Fan J, et al. Biofactors. 2009 May-Jun;35(3):239-48. doi: 10.1002/biof.37. Biofactors. 2009. PMID: 19472365 Review.
Cited by
- Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.
Xiao Z, Wang J, Chen W, Wang P, Zeng H, Chen W. Xiao Z, et al. Lipids Health Dis. 2012 Nov 26;11:163. doi: 10.1186/1476-511X-11-163. Lipids Health Dis. 2012. PMID: 23181436 Free PMC article. - Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.
Gao L, Tian S, Gao H, Xu Y. Gao L, et al. J Mol Neurosci. 2013 Sep;51(1):138-47. doi: 10.1007/s12031-013-9966-y. Epub 2013 Jan 24. J Mol Neurosci. 2013. PMID: 23345083 - Insulin resistance and Alzheimer's disease.
de la Monte SM. de la Monte SM. BMB Rep. 2009 Aug 31;42(8):475-81. doi: 10.5483/bmbrep.2009.42.8.475. BMB Rep. 2009. PMID: 19712582 Free PMC article. Review. - Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer's disease and cardiovascular diseases.
Waigi EW, Webb RC, Moss MA, Uline MJ, McCarthy CG, Wenceslau CF. Waigi EW, et al. Geroscience. 2023 Jun;45(3):1411-1438. doi: 10.1007/s11357-023-00748-y. Epub 2023 Feb 24. Geroscience. 2023. PMID: 36823398 Free PMC article. Review. - Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis.
Gaul S, Shahzad K, Medert R, Gadi I, Mäder C, Schumacher D, Wirth A, Ambreen S, Fatima S, Boeckel JN, Khawaja H, Haas J, Brune M, Nawroth PP, Isermann B, Laufs U, Freichel M. Gaul S, et al. Front Cardiovasc Med. 2022 Mar 8;9:813215. doi: 10.3389/fcvm.2022.813215. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35350534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous